Friday, March 17, 2017
Moximed Gets $50M
Hayward-based Moximed, a developer of implants used to treat patients with knee osteoarthritis (OA), has raised $50M in a Series F funding, the company said this week
The story you have requested is only available to paid members of the silicontap.com web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.